When will the Conivaptan Hydrochloride Injection shortage end?

FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.

Does FDA list alternatives to Conivaptan Hydrochloride Injection?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Conivaptan Hydrochloride Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Conivaptan Hydrochloride Inject…: in shortage

IV bags

A generic iv bag, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

Reason: “Delay in shipping of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Cumberland Pharmaceuticals Inc., Oct 15, 2026

DRUG

Conivaptan Hydrochloride Injection

FDA LISTING

Conivaptan Hydrochloride Injection

FORM

injection

STATUS

Currently in Shortage

FIRST POSTED

Mar 14, 2022

LAST FDA UPDATE

Oct 15, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

FDA lists 1 presentation: 1 unavailable · 0 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Conivaptan Hydrochloride Injection. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Cumberland Pharmaceuticals Inc.1 presentation · 1 unavailable

Contact (FDA's listing): 800-706-5575

20 mg/100 mL
Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
Estimated recovery: TBD
NDC 66220-160-10Reverified Oct 15, 2026
Unavailable

What the manufacturers told FDA

Cumberland Pharmaceuticals Inc. · ‘Estimated recovery: TBD’ · updated Oct 2026

Reason for the shortage (FDASIA)

Delay in shipping of the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Conivaptan Hydrochloride Injection in shortage?: Yes. As of Oct 24, 2026, FDA lists Conivaptan Hydrochloride Injection as currently in shortage: 1 presentations, 1 unavailable and 0 limited.
When will the Conivaptan Hydrochloride Injection shortage end?: FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Conivaptan Hydrochloride Injection?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.